|
26.1.2007 |
EN |
Official Journal of the European Union |
C 18/2 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2006 to 31 December 2006
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))
(2007/C 18/02)
— Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||||
|
4.12.2006 |
Naglazyme |
|
EU/1/05/324/001 |
6.12.2006 |
|||||||
|
4.12.2006 |
Kaletra |
|
EU/1/01/172/001-005 |
8.12.2006 |
|||||||
|
11.12.2006 |
Rotarix |
|
EU/1/05/330/001-004 |
13.12.2006 |
|||||||
|
18.12.2006 |
NeoSpect |
|
EU/1/00/154/001-002 |
21.12.2006 |
|||||||
|
18.12.2006 |
Viracept |
|
EU/1/97/054/003-004 EU/1/97/054/006 |
20.12.2006 |
|||||||
|
18.12.2006 |
ATryn |
|
EU/1/06/355/001-003 |
20.12.2006 |
|||||||
|
19.12.2006 |
SonoVue |
|
EU/1/01/177/001 |
21.12.2006 |
— Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
|
Date of the decision |
Name of the medicinal product |
INN (International Non-Proprietary Name) |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Pharmaceutical form |
ATC code (Anatomical Therapeutic Chemical Code) |
Date of notification |
||||
|
18.12.2006 |
PRAC-TIC |
pyriprole |
|
EU/2/06/066/001-012 |
Spot-on solution |
QP53AX26 |
20.12.2006 |
||||
|
20.12.2006 |
Medicinal Oxygen Air Liquide Santé |
Oxygen |
|
EU/2/06/067/001-002 |
Inhalation gas |
QV03AN01 |
22.12.2006 |
||||
|
19.12.2006 |
ProMeris |
Metaflumizone |
|
EU/2/06/064/001-004 |
Spot-on solution |
QP 53AX25 |
22.12.2006 |
||||
|
19.12.2006 |
ProMeris Duo |
Metaflumizone, Amitraz |
|
EU/2/06/065/001-010 |
Spot-on solution |
QP 53AD51 |
21.12.2006 |
— Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Rejected
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
||
|
11.12.2006 |
Veraflox |
|
- |
14.12.2006 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
|
The European Medicines Agency |
|
7, Westferry Circus, Canary Wharf |
|
London E14 4HB |
|
United Kingdom |
(1) OJ L 136 of 30.4.2004, p. 1.